Evidence map›Paper›PMID 38106429›Full record

ReviewaBIOTECH2023

Predicting rice diseases using advanced technologies at different scales: present status and future perspectives.

Ruyue Li, Sishi Chen, Haruna Matsumoto, Mostafa Gouda, Yusufjon Gafforov, Mengcen Wang, Yufei Liu

Abstract readReview
In one paragraph

Review in aBIOTECH, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Smart agriculture in Asia.Plant communications · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruyue LiCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058 China.
Sishi ChenCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058 China.
Haruna MatsumotoState Key Laboratory of Rice Biology, and Ministry of Agricultural and Rural Affairs Laboratory of Molecular Biology of Crop Pathogens and Insects, Zhejiang University, Hangzhou, 310058 China.
Mostafa GoudaCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058 China.
Yusufjon GafforovCentral Asian Center for Development Studies, New Uzbekistan University, Tashkent, 100000 Uzbekistan.
Mengcen WangState Key Laboratory of Rice Biology, and Ministry of Agricultural and Rural Affairs Laboratory of Molecular Biology of Crop Pathogens and Insects, Zhejiang University, Hangzhou, 310058 China.
Yufei LiuCollege of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past few years have witnessed significant progress in emerging disease detection techniques for accurately and rapidly tracking rice diseases and predicting potential solutions. In this review we focus on image processing techniques using machine learning (ML) and deep learning (DL) models related to multi-scale rice diseases. Furthermore, we summarize applications of different detection techniques, including genomic, physiological, and biochemical approaches. In addition, we also present the state-of-the-art in contemporary optical sensing applications of pathogen-plant interaction phenotypes. This review serves as a valuable resource for researchers seeking effective solutions to address the challenges of high-throughput data and model recognition for early detection of issues affecting rice crops through ML and DL models.

Indexed as

Artificial intelligenceHigh-throughput dataImaging technologyModel algorithmsPlant–pathogen interactionsRice disease

Identifiers

PMID38106429
PMCPMC10721578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.